Representative before the EPO

Employment test 51 - 200 employees
Company dna mathys and squire llp
no operation time available
Headquarter in London and 5 offices
active in Legal Services and Matchmaking and Trading

We have observed 91 EP applications Tobias Rutger Simpson has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11766762

SELECTION AND USE OF HOST CELLS FOR PRODUCTION OF GLYCOPROTEINS

IPC classification:
C07K 1/00, A61K 45/00
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Carpmaels & Ransford LLP
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP11740764

C-MET MODULATOR PHARMACEUTICAL COMPOSITIONS

IPC classification:
A61K 9/20, A61K 31/47
Applicant:
Exelixis Inc
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP11764655

DUAL INHIBITORS OF MET AND VEGF FOR THE TREATMENT OF CASTRATION- RESISTANT PROSTATE CANCER AND OSTEOBLASTIC BONE METASTASES

IPC classification:
A61P 35/00, A61P 35/04, A61K 31/00, A61K 31/47
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12704492

PROCESSES FOR PREPARING QUINOLINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS

IPC classification:
A61P 35/00, C07D 215/227, A61K 31/47
Applicant:
Exelixis Inc
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13151945

c-Met modulators and methods of use

IPC classification:
A61P 35/00, C07D 215/22, A61K 31/47, A61K 31/4709, A61K 31/517
Applicant:
Exelixis Inc
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12720754

METHOD OF TREATING CANCER AND BONE CANCER PAIN

IPC classification:
A61P 35/00, A61K 31/47
Applicant:
Exelixis Inc
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12790362

MODIFIED GLYCOPROTEINS

IPC classification:
C07K 16/00, C12P 21/08
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12730609

DETECTION OF MEMBRANE PROTEIN-THERAPEUTIC AGENT COMPLEXES BY MASS SPECTROMETRY

IPC classification:
B01D 15/38, G01N 33/68, G01N 33/94
Applicant:
Oxford University Innovation Ltd
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13163216

Heterocyclic aspartyl protease inhibitors

IPC classification:
A61P 25/28, C07D 239/20, C07D 401/04, C07D 401/10, C07D 403/04, C07D 405/04, C07D 409/14, C07D 411/04, C07D 417/04, C07D 417/14, C07D 495/20, A61K 31/513
Applicant:
Merck & Co. Inc.
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Agent:
Multiple attorneys, Merck Sharp & Dohme Ltd.
Agent:
Multiple attorneys, Merck Sharp & Dohme Corporation
Status:
PATENT GRANTED
EP13179415

Salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl) -ethoxy}-methyl]-8-phenyl-1,7 -diaza-spiro[4.5]decan-2-one and preparation process therefor

IPC classification:
A61P 1/08, C07D 471/10, A61K 31/438
Agent:
Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13179376

Salts of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor

IPC classification:
A61P 1/08, C07D 471/10, A61K 31/438
Agent:
Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12758591

DEVICE, METHOD AND APPARATUS FOR THE TRANSFER OF ANALYTES

IPC classification:
G01N 30/04, G01N 33/00, G01N 35/10
Applicant:
Oxford University Innovation Ltd
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12757511

TREATMENT OF CANCER

IPC classification:
A61P 35/00, A01N 43/04, A61K 31/44, A61K 31/4745, A61K 45/06
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12770368

METHOD FOR TREATING OSTEOPOROSIS

IPC classification:
A61P 19/10, A61K 31/47
Applicant:
Exelixis Inc
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
PATENT GRANTED
EP13179424

Tosylate Salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl) -ethoxy}-methyl]-8-phenyl-1,7 -diaza-spiro[4.5]decan-2-one and preparation process therefor

IPC classification:
A61P 1/08, C07D 471/10, A61K 31/435, A61K 31/438, A61K 31/495
Agent:
Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12775050

ASYMMETRIC SYNTHESIS OF ORGANIC COMPOUNDS

IPC classification:
C07B 53/00, C07C 45/69, C07C 49/403, C07C 49/413, C07C 49/463
Applicant:
Oxford University Innovation Ltd
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12783763

PROCESS FOR PREPARING QUINOLINE DERIVATIVES

IPC classification:
C07C 231/02, C07C 233/59, C07D 215/22, C07D 413/12
Applicant:
Exelixis Inc
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12753313

TREATMENTS FOR GASTROINTESTINAL DISORDERS

IPC classification:
C07K 7/54, A61K 38/10
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
PATENT GRANTED
EP12787328

DUAL INHIBITOR OF MET AND VEGF FOR TREATING CANCER

IPC classification:
A61P 35/00, A61K 31/47, A61K 31/517, A61K 35/04
Applicant:
Exelixis Inc
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13736214

NUCLEOTIDE CLONING METHODS

IPC classification:
C12N 15/00
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13743255

CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY

IPC classification:
C08B 37/16
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13743529

POLYMER-AGENT CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USE

IPC classification:
A61P 35/00, A61K 9/00, A61K 47/48
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13743111

CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY

IPC classification:
C08B 37/16, A61K 31/715
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP11758343

TREATMENT OF CONSTIPATION-PREDOMINANT IRRITABLE BOWEL SYNDROME

IPC classification:
A61P 1/00, A61P 43/00, A61K 38/10
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13714993

PROCESS FOR PRODUCING TWO-DIMENSIONAL NANOMATERIALS

IPC classification:
B82Y 40/00, C01B 31/04, C23C 16/26, C30B 25/16, C30B 25/18, C30B 29/02
Applicant:
Oxford University Innovation Ltd
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13751423

CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS

IPC classification:
C08F 290/14, C12N 5/00, C12N 15/11, A61K 48/00
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13724470

COATED MEDICAL DEVICES COMPRISING A WATER - INSOLUBLE THERAPEUTIC AGENT AND AN ADDITIVE

IPC classification:
A61F 2/915, A61F 2/958, A61K 9/00, A61K 31/337, A61K 31/715, A61K 31/727, A61M 25/10
Applicant:
Cook Medical Technologies LLC
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13781339

MODIFIED GLYCOPROTEINS

IPC classification:
C07K 16/00, A61K 39/395
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP13722238

A DUAL MET - VEGF MODULATOR FOR TREATING OSTEOLYTIC BONE METASTASES

IPC classification:
A61P 35/04, A61K 31/47
Applicant:
Exelixis Inc
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14184656

Anti-tumor macrophage m1 morphology inducer

IPC classification:
A61L 31/16
Applicant:
Cook Medical Technologies LLC
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13797204

COMBINED THERAPY AND PROPHYLAXIS FOR GENITAL TRACT INFECTIONS

IPC classification:
A61K 9/50
Applicant:
The State University of New York
Applicant:
State University of New York University at Buffalo - Office Of Science Technology Transfer
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
PATENT GRANTED
EP13807428

MESOPOROUS OXIDE NANOPARTICLES AND METHODS OF MAKING AND USING SAME

IPC classification:
A61K 9/14, A61K 9/16, A61K 47/02, A61K 47/30
Applicant:
Cornell University
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13765886

INHIBITORS OF MET, VEGFR AND RET FOR USE IN THE TREATMENT OF LUNG ADENOCARCINOMA

IPC classification:
A61P 35/00, A61K 31/47
Applicant:
Exelixis Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13843562

TREATMENT OF CANCER

IPC classification:
A61P 35/00, A61K 31/724, A61K 39/395
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13858461

METHODS OF MODULATING FOLLICLE STIMULATING HORMONE ACTIVITY

IPC classification:
A61K 45/00
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13865112

COMPOSITIONS AND METHOD FOR LIGHT TRIGGERED RELEASE OF MATERIALS FROM NANOVESICLES

IPC classification:
C07D 487/22, A61B 5/00
Applicant:
State University of New York University at Buffalo - Office Of Science Technology Transfer
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13821708

DETECTION OF MEMBRANE PROTEINS

IPC classification:
G01N 33/68
Applicant:
Oxford University Innovation Ltd
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14746208

AQUEOUS OPHTHALMIC SOLUTIONS OF PHENTOLAMINE AND MEDICAL USES THEREOF

IPC classification:
A01N 43/42, A61K 31/44
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14746563

METHODS AND COMPOSITIONS FOR DAILY OPHTHALMIC ADMINISTRATION OF PHENTOLAMINE TO IMPROVE VISUAL PERFORMANCE

IPC classification:
A61K 31/517
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14769180

METHODS OF CELL CULTURE

IPC classification:
A61K 39/395
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14776142

METHODS OF CELL CULTURE

IPC classification:
C12N 5/00, C12N 5/02, C12P 1/00
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14721149

METABOLITES OF N-(4-{[6,7-BIS(METHYLOXY)QUINOLIN-4-YL]OXY}PHENYL)-N'-(4-FLUOROPHENYL) CYCLOPROPANE-1,1-DICARBOXAMIDE

IPC classification:
A61P 35/00, C07C 233/60, C07C 305/24, C07D 215/22, A61K 31/47
Applicant:
Exelixis Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14775649

METHODS OF CELL CULTURE

IPC classification:
C12N 5/00, C12N 5/07, C12P 21/04
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14775563

ENHANCEMENT OF VACCINES

IPC classification:
A61P 35/00, A61P 37/02, A61K 39/395
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14770567

ION-CONDUCTING BATTERIES WITH SOLID STATE ELECTROLYTE MATERIALS

IPC classification:
H01M 6/18, H01M 8/10, H01M 8/24
Applicant:
University of Maryland College Park
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14724909

CABOZANTINIB DOSAGE FORM AND USE IN THE TREATMENT OF CANCER

IPC classification:
A61P 35/00, A61K 31/47
Applicant:
Exelixis Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15179160

ENCAPSULATED DRUG COMPOSITIONS AND METHODS OF USE THEREOF

IPC classification:
A61K 31/353, A61L 27/34, A61L 27/54, A61L 29/08, A61L 29/16, A61L 31/10, A61L 31/16
Applicant:
Cook Medical Technologies LLC
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15179148

COMPOSITIONS AND DEVICES INCORPORATING WATER-INSOLUBLE THERAPEUTIC AGENTS AND METHODS OF THE USE THEREOF

IPC classification:
A61K 31/353, A61L 27/34, A61L 27/44, A61L 27/54, A61L 29/08, A61L 29/16, A61L 31/10, A61L 31/16
Applicant:
Cook Medical Technologies LLC
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14770577

CITRATE CONTAINING BEVERAGE

IPC classification:
A61P 3/02, A61P 3/14, A23L 2/385, A23L 2/52, A61K 31/19
Applicant:
New York University
Applicant:
University of California
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14724594

DRUG COMBINATIONS TO TREAT CANCER

IPC classification:
A61P 35/00, A61K 9/00, A61K 31/47, A61K 31/517, A61K 31/575, A61K 31/58
Applicant:
Exelixis Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14794026

USE OF LAPPAOL F TO INHIBIT TUMOR CELL GROWTH

IPC classification:
A61K 31/015
Applicant:
Guangzhou University of Chinese Medicine
Applicant:
Suny Upstate Medical University
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14798473

METHODS FOR THE TREATMENT OF NEURODEGENERATION

IPC classification:
A61P 25/28
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14804677

POLYSACCHARIDE COMPOSITIONS AND RELATED METHODS

IPC classification:
C08B 37/10, C08L 5/10, A61K 31/727
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14803492

PHARMACEUTICAL COMPOSITIONS COMPRISING PYROPHOSPHATE

IPC classification:
C01B 25/42, A61K 39/395, A61K 47/42
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14805110

PHARMACEUTICAL COMPOSITIONS

IPC classification:
C08B 37/10, C08L 5/10, A61K 31/727
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP11769624

POLYSACCHARIDE COMPOSITIONS AND METHODS OF USE FOR THE TREATMENT AND PREVENTION OF DISORDERS ASSOCIATED WITH PROGENITOR CELL MOBILIZATION

IPC classification:
A61P 35/00, A61P 35/04, C08B 37/00, A61K 31/727, A61K 39/395, A61K 45/06
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11784186

COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE AND OTHER DISEASES

IPC classification:
A61P 29/00, A61P 37/00, C08B 37/16, A61K 47/00, A61K 47/48
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14791856

RECHARGEABLE POWER SOURCE FOR MOBILE DEVICES WHICH INCLUDES AN ULTRACAPACITOR

IPC classification:
H01G 11/22, H01G 11/36
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14823331

LINE IMMUNOASSAY TESTING DEVICE

IPC classification:
G01N 35/04
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14766283

BIOACTIVE COMPOSITIONS DERIVABLE FROM PLATELET CONCENTRATES, AND METHODS FOR PREPARING AND USING SAME

IPC classification:
C12N 5/00, A61K 35/14, A61K 38/18
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14863671

CORE-SHELL NANOPARTICLES, METHODS OF MAKING SAME, AND USES OF SAME

IPC classification:
B82Y 30/00, C01F 17/00
Applicant:
State University of New York University at Buffalo - Office Of Science Technology Transfer
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14843496

MACROCYCLES, COBALT AND IRON COMPLEXES OF SAME, AND METHODS OF MAKING AND USING SAME

IPC classification:
A61K 49/12
Applicant:
State University of New York University at Buffalo - Office Of Science Technology Transfer
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14848904

COMPOSITIONS AND METHODS FOR REDUCING ANTIGEN-SPECIFIC IMMUNOGENICITY

IPC classification:
C07F 9/09, A61K 39/00
Applicant:
State University of New York University at Buffalo - Office Of Science Technology Transfer
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14849624

TREATMENT OF CANCER

IPC classification:
A61K 31/404
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14847723

SYSTEM AND METHOD FOR REMOVING TRANSITION METALS FROM SOLUTION

IPC classification:
C22B 3/00
Applicant:
State University of New York University at Buffalo - Office Of Science Technology Transfer
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP11766759

METHOD FOR QUANTIFYING HIGH MANNOSE CONTAINING GLYCOFORMS

IPC classification:
C12P 21/00, C12Q 1/34, G01N 33/68
Applicant:
Momenta Pharmaceuticals Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
PATENT GRANTED
EP11713509

ALUMINA-BASED CERAMIC MATERIALS AND PROCESS FOR THE PRODUCTION THEREOF

IPC classification:
C04B 35/111
Applicant:
Oxford University Innovation Ltd
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP11794888

SUSTAINABLE PACKAGING FOR CONSUMER PRODUCTS

IPC classification:
B65D 1/00
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Agent:
Multiple attorneys, Procter & Gamble Service GmbH
Status:
PATENT GRANTED
EP16704085

GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF

IPC classification:
A61K 45/06
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
The patent has been granted
EP15162515

DIESEL EXHAUST FLUID SOLUTIONS AND METHODS OF USING THE SAME

IPC classification:
B01D 53/90, B01D 53/94, C07C 69/40
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP16165628

MONOLAYER FILMS OF SEMICONDUCTING METAL DICHALCOGENIDES, METHODS OF MAKING SAME, AND USES OF SAME

IPC classification:
H01L 21/02
Applicant:
Cornell University
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14870517

VENTILATION DEVICES AND METHODS

IPC classification:
B65D 90/34
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14824655

DELAYED RELEASE COMPOSITIONS OF LINACLOTIDE

IPC classification:
A61K 9/16, A61K 9/20, A61K 9/28, A61K 9/48, A61K 9/50, A61K 38/10
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14875542

BENZAMIDE AND NICOTINAMIDE COMPOUNDS AND METHODS OF USING SAME

IPC classification:
C07C 237/22, A61K 31/166, A61K 31/4155
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15752637

COMBINATION THERAPY FOR HEPATOCELLULAR CARCINOMA

IPC classification:
A61K 31/435
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP12166767

Cosmetic composition in a container

IPC classification:
A61Q 5/12, A61K 8/04, A61K 8/19, A61K 8/34, A61K 8/41
Applicant:
The Procter & Gamble Company
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Agent:
Verena Clarita Töpert, Procter & Gamble Service GmbH
Status:
PATENT GRANTED
EP15714340

DOSING OF CABOZANTINIB FORMULATIONS

IPC classification:
A61P 35/00, C07C 233/60, C07C 305/24, C07D 215/22, A61K 9/00, A61K 9/20, A61K 9/48, A61K 31/47
Applicant:
Exelixis Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15710315

CRYSTALLINE SOLID FORMS OF N-{4-[(6,7-DIMETHOXYQUINOLIN-4-YL)OXY]PHENYL}-N'-(4-FLUOROPHENYL) CYCLOPROPANE-1, 1-DICARBOXAMIDE, PROCESSES FOR MAKING, AND METHODS OF USE

IPC classification:
A61P 35/00, C07D 215/22, A61K 31/47
Applicant:
Exelixis Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15712504

METHODS AND COMPOSITIONS FOR IMMUNOMODULATION

IPC classification:
C12N 5/07, A61K 35/12, A61K 39/00
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15780722

COMPOSITE NANOMATERIALS AND MICROMATERIALS, FILMS OF SAME, AND METHODS OF MAKING AND USES OF SAME

IPC classification:
C01G 31/02
Applicant:
State University of New York University at Buffalo - Office Of Science Technology Transfer
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15721100

METHOD OF TREATING LUNG ADENOCARCINOMA

IPC classification:
A61P 35/00, A61K 31/337, A61K 31/47, A61K 31/517, A61K 31/7068
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15716568

PROCESS FOR THE PRODUCTION OF TWO-DIMENSIONAL NANOMATERIALS

IPC classification:
C01B 32/182, C23C 16/00, C23C 16/26, C23C 16/34
Applicant:
Oxford University Innovation Ltd
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15815151

SURFACTANT-STRIPPED MICELLE COMPOSITIONS WITH HIGH CARGO TO SURFACTANT RATIO

IPC classification:
A61K 9/107
Applicant:
State University of New York University at Buffalo - Office Of Science Technology Transfer
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15821872

USE OF HYALURONIDASE FOR TREATMENT OF MUSCLE STIFFNESS

IPC classification:
A61K 38/47
Applicant:
New York University
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15750223

DRUG COMBINATIONS TO TREAT MULTIPLE MYELOMA

IPC classification:
A61K 31/194, A61K 31/47, A61K 31/4965, A61K 31/69, A61K 38/05
Applicant:
Exelixis Inc
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15841872

IDENTIFYING STATUS OF MALE FERTILITY BY DETERMINING SPERM CAPACITATION

IPC classification:
C07K 2/00
Applicant:
Cornell University
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
Request for examination was made
EP15835382

VO2 AND V2O5 NANO-AND MICRO-MATERIALS AND PROCESSES OF MAKING AND USES OF SAME

IPC classification:
C01G 31/02
Applicant:
State University of New York University at Buffalo - Office Of Science Technology Transfer
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
Request for examination was made
EP15848315

FUNCTIONAL SEGREGATED TELODENDRIMERS AND NANOCARRIERS AND METHODS OF MAKING AND USING SAME

IPC classification:
A61K 47/50, A61K 47/34
Applicant:
State University of New York - Office of Technology Transfer
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
Request for examination was made
EP15784445

BATTERY CHARGER

IPC classification:
H01G 11/32, H02J 7/00, H02J 7/34
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
Request for examination was made
EP16203557

SALTS, PRODRUGS AND POLYMORPHS OF FAB I INHIBITORS

IPC classification:
A61P 31/04, C07D 471/04, C07F 9/22, A61K 31/4375, A61L 2/16
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
The application has been published
EP16718913

GLYCOPEPTIDES CONJUGATES AND USES THEREOF

IPC classification:
A61P 31/04, C07K 9/00, A61K 38/14
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
Request for examination was made

Please Sign in to use this feature